[
  {
    "ts": null,
    "headline": "JPM26: Medtronic touts billion-dollar market opportunity for Altaviva",
    "summary": "Medtronic revealed that since Altaviva’s FDA approval in September 2025, 500 physicians have been trained to deploy the urinary incontinence implantable.",
    "url": "https://finnhub.io/api/news?id=537a934cebe3450b85d78eefef073f02a1e2d18b056a3b6a23679ce0d5d8a47c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768331257,
      "headline": "JPM26: Medtronic touts billion-dollar market opportunity for Altaviva",
      "id": 138092570,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic revealed that since Altaviva’s FDA approval in September 2025, 500 physicians have been trained to deploy the urinary incontinence implantable.",
      "url": "https://finnhub.io/api/news?id=537a934cebe3450b85d78eefef073f02a1e2d18b056a3b6a23679ce0d5d8a47c"
    }
  },
  {
    "ts": null,
    "headline": "3 MedTech Stocks Benefiting From Favorable Product Mix Shifts",
    "summary": "ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.",
    "url": "https://finnhub.io/api/news?id=44f04aa907d26732f3c33eafd994906fa3818290ec07c5e88868b8e48ce2431b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768329600,
      "headline": "3 MedTech Stocks Benefiting From Favorable Product Mix Shifts",
      "id": 138092371,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.",
      "url": "https://finnhub.io/api/news?id=44f04aa907d26732f3c33eafd994906fa3818290ec07c5e88868b8e48ce2431b"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Partners With Precision Neuroscience to Develop Brain Surgery Imaging System",
    "summary": "Medtronic will access anonymized brain data and co-develop a surgical system mapping neural activity in real time.",
    "url": "https://finnhub.io/api/news?id=0c1817177c08ec90f8b8376367b9795f66f9fa993bbc716d7d66a1b41f367593",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768327359,
      "headline": "Medtronic Partners With Precision Neuroscience to Develop Brain Surgery Imaging System",
      "id": 138086826,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic will access anonymized brain data and co-develop a surgical system mapping neural activity in real time.",
      "url": "https://finnhub.io/api/news?id=0c1817177c08ec90f8b8376367b9795f66f9fa993bbc716d7d66a1b41f367593"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: Medtronic touts ‘multi-billion’ dollar potential of key markets",
    "summary": "Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the near future.",
    "url": "https://finnhub.io/api/news?id=bdb633431e5d592028534d57c9f2aac262bb855deb614fb416ce3350a2ca887b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768324780,
      "headline": "JPM26: Medtronic touts ‘multi-billion’ dollar potential of key markets",
      "id": 138086815,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the near future.",
      "url": "https://finnhub.io/api/news?id=bdb633431e5d592028534d57c9f2aac262bb855deb614fb416ce3350a2ca887b"
    }
  },
  {
    "ts": null,
    "headline": "Zip Launches Enterprise Transformation Office, Tapping Former Fortune 500 CPOs to Guide Procurement Leaders Through AI-Era Change",
    "summary": "SAN FRANCISCO, January 13, 2026--Zip Launches Enterprise Transformation Office, Tapping Former Fortune 500 CPOs to Guide Procurement Leaders Through AI-Era Change",
    "url": "https://finnhub.io/api/news?id=86c86e4b25b508d762d9ac588d44f23911d30185b33366f70ad628327227edba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768312800,
      "headline": "Zip Launches Enterprise Transformation Office, Tapping Former Fortune 500 CPOs to Guide Procurement Leaders Through AI-Era Change",
      "id": 138084523,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "SAN FRANCISCO, January 13, 2026--Zip Launches Enterprise Transformation Office, Tapping Former Fortune 500 CPOs to Guide Procurement Leaders Through AI-Era Change",
      "url": "https://finnhub.io/api/news?id=86c86e4b25b508d762d9ac588d44f23911d30185b33366f70ad628327227edba"
    }
  },
  {
    "ts": null,
    "headline": "Oramed and Lifeward Announce Strategic Transaction",
    "summary": "Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (\"Oramed\") and Lifeward Ltd. (NASDAQ: LFWD) (\"Lifeward\") today announced the signing of binding agreements for a strategic transaction between Oramed, Lifeward and a certain accredited investor. The transaction includes the transfer to Lifeward of Oramed's proprietary Protein Oral Drug POD™ delivery technology and Oramed obtaining 49.9% beneficial ownership interest in Lifeward upon the satisfaction of certain terms and conditions. In addit",
    "url": "https://finnhub.io/api/news?id=e18e03f686190edd3707370d46559505ee98af9b8091de6eef6fddcd7e10dc1e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768309080,
      "headline": "Oramed and Lifeward Announce Strategic Transaction",
      "id": 138083466,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (\"Oramed\") and Lifeward Ltd. (NASDAQ: LFWD) (\"Lifeward\") today announced the signing of binding agreements for a strategic transaction between Oramed, Lifeward and a certain accredited investor. The transaction includes the transfer to Lifeward of Oramed's proprietary Protein Oral Drug POD™ delivery technology and Oramed obtaining 49.9% beneficial ownership interest in Lifeward upon the satisfaction of certain terms and conditions. In addit",
      "url": "https://finnhub.io/api/news?id=e18e03f686190edd3707370d46559505ee98af9b8091de6eef6fddcd7e10dc1e"
    }
  },
  {
    "ts": null,
    "headline": "What's Powering J&J's MedTech Growth Ahead of Q4 Release?",
    "summary": "JNJ's MedTech unit is gaining momentum from cardiovascular strength and new products, even as China pressure lingers into the next quarter.",
    "url": "https://finnhub.io/api/news?id=f85c3faba5d5edacb66dd7bb56ac9b9e68dfef94d6bd3d8a2ebdf1b63e56dd0c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768308480,
      "headline": "What's Powering J&J's MedTech Growth Ahead of Q4 Release?",
      "id": 138084497,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "JNJ's MedTech unit is gaining momentum from cardiovascular strength and new products, even as China pressure lingers into the next quarter.",
      "url": "https://finnhub.io/api/news?id=f85c3faba5d5edacb66dd7bb56ac9b9e68dfef94d6bd3d8a2ebdf1b63e56dd0c"
    }
  }
]